estriol has been researched along with norethindrone acetate in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 17 (70.83) | 18.7374 |
| 1990's | 4 (16.67) | 18.2507 |
| 2000's | 2 (8.33) | 29.6817 |
| 2010's | 1 (4.17) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Byrjalsen, I; Christiansen, C; Riis, BJ | 1 |
| Dören, M; Montag, M; Schneider, HP | 1 |
| Cullberg, G; Mattsson, LA; Samsioe, G | 2 |
| Christiansen, C; Jensen, J; Nilas, L | 1 |
| Staland, B | 2 |
| Mattsson, LA; Samsioe, G | 1 |
| Baraghini, F; Barbieri, C; Dalla Vecchia, E; Di Renzo, GC; Grasso, A; Previdi, AM; Volpe, A | 1 |
| Altmann, G; Bernaschek, G; Feichtinger, W; Kemeter, P | 1 |
| Hellberg, D; Nilsson, S | 1 |
| Catherwood, BD; Christiansen, C; Deftos, LJ; Pødenphant, J | 1 |
| Christiansen, C; Rødbro, P | 1 |
| Christensen, MS; Christiansen, C; Hagen, C; Rødbro, P; Transbøl, I | 1 |
| Christensen, MS; Christiansen, C; Hagen, C; Transbøl, I | 1 |
| Christensen, MS; Christiansen, C; Hagen, C; Stocklund, KE; Transbøl, I | 1 |
| Christiansen, C; Jensen, GF; Transbøl, I | 1 |
| Collins, A; Eneroth, P; Frankenhaeuser, M; Hagenfeldt, K; Hanson, U; Lundberg, U | 1 |
| Klehr-Bathmann, I; Kuhl, H | 1 |
| Rachev, E | 1 |
| Dören, M; Schneider, HP | 1 |
| Bilgen, I; Bilgin, O; Coşan Terek, M; Memiş, A; Ozşener, S; Oztekin, K; Sendağ, F | 1 |
| Bacchi Modena, A; Baldini, M; Benassi, L; Dei Cas, A; Luciana Barilli, A; Manotti, C; Rinaldi, M; Sgarabotto, M | 1 |
8 trial(s) available for estriol and norethindrone acetate
| Article | Year |
|---|---|
[Prospective perimenopausal estrogen-progestin substitution therapies for the prevention of osteoporosis].
Topics: Clinical Trials as Topic; Drug Therapy, Combination; Estradiol; Estriol; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Osteoporosis, Postmenopausal; Prospective Studies | 1989 |
Serum bone Gla protein variations during estrogen and calcium prophylaxis of postmenopausal women.
Topics: Alkaline Phosphatase; Bone and Bones; Calcium; Calcium-Binding Proteins; Estradiol; Estriol; Estrogens; Female; Humans; Menopause; Minerals; Norethindrone; Norethindrone Acetate; Osteocalcin | 1984 |
Effect of 1,25-dihydroxy-vitamin D3 in itself or combined with hormone treatment in preventing postmenopausal osteoporosis.
Topics: Bone and Bones; Calcitriol; Calcium; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Estradiol; Estriol; Estrogens; Female; Humans; Menopause; Middle Aged; Minerals; Norethindrone; Norethindrone Acetate; Osteoporosis; Phosphates; Progestins | 1981 |
Long-term effects of oestrogens in combination with gestagen on plasma prolactin and FSH levels in post-menopausal women.
Topics: Clinical Trials as Topic; Dose-Response Relationship, Drug; Estradiol; Estriol; Female; Follicle Stimulating Hormone; Humans; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Placebos; Prolactin; Radioimmunoassay; Random Allocation; Time Factors | 1982 |
Continuous treatment with natural oestrogens and progestogens. A method to avoid endometrial stimulation.
Topics: Adult; Aged; Biopsy; Clinical Trials as Topic; Drug Combinations; Endometrium; Estradiol; Estriol; Female; Humans; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Random Allocation | 1981 |
Treatment of post menopausal osteoporosis. A controlled therapeutic trial comparing oestrogen/gestagen, 1,25-dihydroxy-vitamin D3 and calcium.
Topics: Aged; Bone and Bones; Calcitriol; Calcium; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Estradiol; Estriol; Female; Humans; Menopause; Norethindrone; Norethindrone Acetate; Osteoporosis | 1982 |
[Kliogest--the possibility of hormonal substitution in the postmenopause].
Topics: Drug Combinations; Estradiol; Estriol; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Time Factors | 1993 |
Effects of raloxifene and continuous combined hormone therapy on haemostasis variables: a multicenter, randomized, double-blind study.
Topics: Aged; Body Mass Index; Contraceptives, Oral, Synthetic; Double-Blind Method; Drug Combinations; Estradiol; Estriol; Female; Hemostasis; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Time Factors | 2007 |
16 other study(ies) available for estriol and norethindrone acetate
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Serum placental protein 14 in pre-menopausal and post-menopausal women--dependency on oestrogen/progestogen status.
Topics: Adult; Estradiol; Estriol; Estrogen Replacement Therapy; Female; Glycodelin; Glycoproteins; Humans; Menopause; Menstrual Cycle; Middle Aged; Norethindrone; Norethindrone Acetate; Pregnancy Proteins; Progesterone | 1990 |
The relative fatty acid composition of serum lecithin and cholesterol ester: influence of an estrogen-progestogen regimen in climacteric women.
Topics: Adult; Cholesterol Esters; Climacteric; Drug Combinations; Estradiol; Estriol; Fatty Acids; Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Phosphatidylcholines | 1986 |
Cyclic changes in serum cholesterol and lipoproteins following different doses of combined postmenopausal hormone replacement therapy.
Topics: Cholesterol; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Estradiol; Estriol; Estrogens; Female; Humans; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate | 1986 |
Continuous treatment with a combination of estrogen and gestagen--a way of avoiding endometrial stimulation. Clinical experiences with Kliogest.
Topics: Atrophy; Climacteric; Drug Combinations; Endometrium; Estradiol; Estriol; Female; Humans; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate | 1985 |
Estrogen-progestogen replacement in climacteric women, particularly as regards a new type of continuous regimen.
Topics: Adult; Climacteric; Drug Combinations; Endometrium; Estradiol; Estriol; Female; Humans; Lipids; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate | 1985 |
Endocrinological features and endometrial morphology in climacteric women receiving hormone replacement therapy.
Topics: Climacteric; Endometrium; Estradiol; Estriol; Estrogens; Estrogens, Conjugated (USP); Estrone; Female; Follicle Stimulating Hormone; Gonadotropins, Pituitary; Humans; Luteinizing Hormone; Norethindrone; Norethindrone Acetate; Prolactin | 1982 |
The effect of 2 mg estradiol-17 beta plus 1 mg estriol, sequentially combined with 1 mg norethisteroneacetate, on LH, FSH, estradiol-17 beta, progesterone, testosterone and prolactin after ovariectomy.
Topics: Adult; Castration; Estradiol; Estriol; Female; Follicle Stimulating Hormone; Gonadotropins, Pituitary; Humans; Luteinizing Hormone; Middle Aged; Norethindrone; Norethindrone Acetate; Progesterone; Prolactin; Testosterone | 1984 |
Comparison of a triphasic oestradiol/norethisterone acetate preparation with and without an oestriol component in the treatment of climacteric complaints.
Topics: Adult; Climacteric; Double-Blind Method; Drug Combinations; Drug Evaluation; Endometrium; Estradiol; Estriol; Female; Follicle Stimulating Hormone; Humans; Liver; Liver Function Tests; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Random Allocation | 1984 |
A continuous estrogen-progestogen regimen for climacteric complaints. Effects on lipid and lipoprotein metabolism.
Topics: Adult; Climacteric; Drug Combinations; Estradiol; Estriol; Female; Humans; Lipids; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Time Factors | 1984 |
Does postmenopausal bone loss respond to estrogen replacement therapy independent of bone loss rate?
Topics: Aged; Bone and Bones; Drug Therapy, Combination; Estradiol; Estradiol Congeners; Estriol; Female; Follow-Up Studies; Humans; Menopause; Middle Aged; Minerals; Norethindrone; Norethindrone Acetate; Osteoporosis | 1983 |
Effects of two years' estrogen-gestagen replacement on climacteric symptoms and gonadotropins in the early postmenopausal period.
Topics: Bendroflumethiazide; Climacteric; Estradiol; Estriol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Time Factors | 1982 |
Psychophysiological stress responses in postmenopausal women before and after hormonal replacement therapy.
Topics: Adult; Blood Pressure; Drug Therapy, Combination; Estradiol; Estriol; Female; Heart Rate; Hormones; Humans; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Stress, Psychological; Sweating | 1982 |
Formation of ethinylestradiol in postmenopausal women during continuous treatment with a combination of estradiol, estriol and norethisterone acetate.
Topics: Aged; Estradiol; Estriol; Estrogen Replacement Therapy; Ethinyl Estradiol; Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause | 1995 |
Long-term compliance of continuous combined estrogen and progestogen replacement in postmenopausal women.
Topics: Adult; Aged; Climacteric; Drug Administration Schedule; Drug Therapy, Combination; Estradiol; Estriol; Estrogen Replacement Therapy; Female; Follow-Up Studies; Gonadal Steroid Hormones; Humans; Levonorgestrel; Long-Term Care; Medroxyprogesterone Acetate; Menstrual Cycle; Middle Aged; Norethindrone; Norethindrone Acetate; Patient Compliance; Progestins | 1996 |
Mammographic density changes during different postmenopausal hormone replacement therapies.
Topics: Cyproterone Acetate; Drug Combinations; Estradiol; Estriol; Estrogen Replacement Therapy; Estrogens; Female; Humans; Mammography; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Postmenopause; Progesterone Congeners; Retrospective Studies; Time Factors | 2001 |